| Application no. and date | 07750153.4 (espacenet) (Federated) (European Patent Register), 20070207 | | Patent/reg. no. and date | DK/EP 2114367, 20151104 | | Publication date | 20091111 | | Priority no. and date | | | EP pub. no. and date |
EP 2114367 20091111 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | P81504478DK00E | | Inventor | HAN, Wesley, Wehsin, 2400 Winding Hollow Lane
Arlington, TX 76006, US,
SINGH, Onkar, N., 5606 Rachel Court
Arlington, TX 76017, US,
JANI, Rajni, 4621 Briarhaven Road
Fort Worth, TX 76109, US,
WALL, G., Michael, 4417 Ledgeview Road
Forth Worth, TX 76109, US,
CHOWHAN, Masood, A., 3521 Lake Tahoe Drive
Arlington, TX 76016, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/335 (2006.01) , A61K 9/00 (2006.01) | | Title | OLOPATADIN-FORMULERINGER TIL TOPISK NASAL INDGIVELSE | | Int. application no. | US2007003285 | | Int. publication no. | WO2008097220 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
